Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 196,754 | N/A | N/A | N/A | 57,461 |
| Other current assets | 0 | 0 | 0 | 0 | 791 |
| TOTAL | $198,182 | $N/A | $N/A | $N/A | $58,252 |
| Non-Current Assets | |||||
| PPE Net | 838 | N/A | N/A | N/A | 1,280 |
| Other Non-Current Assets | 75 | 0 | 0 | 0 | 170 |
| TOTAL | $913 | $N/A | $N/A | $N/A | $1,450 |
| Total Assets | $199,095 | $N/A | $N/A | $N/A | $58,945 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,395 | 0 | 0 | 0 | 1,410 |
| Accrued Expenses | 9,233 | N/A | N/A | N/A | 2,950 |
| TOTAL | $13,815 | $N/A | $N/A | $N/A | $4,557 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,294 | N/A | N/A | N/A | 1,481 |
| Other Non-Current Liabilities | 13 | 0 | 0 | 0 | 0 |
| TOTAL | $1,307 | $N/A | $N/A | $N/A | $1,481 |
| Total Liabilities | $15,122 | $N/A | $N/A | $N/A | $6,038 |
| Shareholders' Equity | |||||
| Common Shares | 326 | N/A | N/A | N/A | 0 |
| Retained earnings | -195,869 | N/A | N/A | N/A | -145,585 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 192,672 |
| TOTAL | $183,973 | $N/A | $N/A | $N/A | $52,907 |
| Total Liabilities And Equity | $199,095 | $0 | $0 | $0 | $58,945 |